Krensavage Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.49M Buy
958,877
+8,877
+0.9% +$78.6K 4.49% 9
2025
Q1
$7.44M Buy
+950,000
New +$7.44M 4.11% 11